Similar articles for PMID: 25607510

Year	Number of Results
2005	1
2006	3
2007	1
2008	6
2009	4
2010	3
2011	5
2012	4
2013	4
2014	13
2015	4
2017	1
2018	6
2019	5
2020	1
2021	1
2022	4
2024	0

1

Echinocandin use in hospitalized patients: a multi-institutional study.

Garey KW, Aitken SL, Dima-Ala A, Beyda ND, Kuper K, Xie Y, Koo HL. Garey KW, et al. Am J Med Sci. 2015 Apr;349(4):316-20. doi: 10.1097/MAJ.0000000000000412. Am J Med Sci. 2015. PMID: 25607510

2

Treatment of candidemia with echinocandins: data on hospital resource use from a real world setting.

Wade RL, Chaudhari P, Campbell RS, Hays HD, Nathanson BH, Yi J, Horn D. Wade RL, et al. J Med Econ. 2012;15(6):1130-8. doi: 10.3111/13696998.2012.708690. Epub 2012 Jul 13. J Med Econ. 2012. PMID: 22788668 Free article.

3

FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.

Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. Beyda ND, et al. Clin Infect Dis. 2014 Sep 15;59(6):819-25. doi: 10.1093/cid/ciu407. Epub 2014 May 30. Clin Infect Dis. 2014. PMID: 24879785

4

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC. Arendrup MC. Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Free article. Review.

5

Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study.

Garnacho-Montero J, Díaz-Martín A, Cantón-Bulnes L, Ramírez P, Sierra R, Arias-Verdú D, Rodríguez-Delgado M, Loza-Vázquez A, Rodriguez-Gomez J, Gordón M, Estella Á, García-Garmendia JL. Garnacho-Montero J, et al. Crit Care Med. 2018 Mar;46(3):384-393. doi: 10.1097/CCM.0000000000002867. Crit Care Med. 2018. PMID: 29189345

6

Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia.

Eschenauer GA, Nguyen MH, Clancy CJ. Eschenauer GA, et al. Ann Pharmacother. 2015 Sep;49(9):1068-74. doi: 10.1177/1060028015590838. Epub 2015 Jun 23. Ann Pharmacother. 2015. PMID: 26104051 Review.

7

Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.

Fernández-Ruiz M, Aguado JM, Almirante B, Lora-Pablos D, Padilla B, Puig-Asensio M, Montejo M, García-Rodríguez J, Pemán J, Ruiz Pérez de Pipaón M, Cuenca-Estrella M; CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI. Fernández-Ruiz M, et al. Clin Infect Dis. 2014 May;58(10):1413-21. doi: 10.1093/cid/ciu158. Epub 2014 Mar 18. Clin Infect Dis. 2014. PMID: 24642553

8

Treatment of invasive candidiasis: between guidelines and daily clinical practice.

Tagliaferri E, Menichetti F. Tagliaferri E, et al. Expert Rev Anti Infect Ther. 2015 Jun;13(6):685-9. doi: 10.1586/14787210.2015.1029916. Epub 2015 Mar 27. Expert Rev Anti Infect Ther. 2015. PMID: 25818660

9

Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.

Lee SC, Lee CW, Shih HJ, Huang SH, Chiou MJ, See LC. Lee SC, et al. J Microbiol Immunol Infect. 2014 Jun;47(3):245-53. doi: 10.1016/j.jmii.2013.09.006. Epub 2013 Nov 15. J Microbiol Immunol Infect. 2014. PMID: 24246191 Free article.

10

Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU.

Bruyère R, Quenot JP, Prin S, Dalle F, Vigneron C, Aho S, Leon C, Charles PE. Bruyère R, et al. BMC Infect Dis. 2014 Jul 11;14:385. doi: 10.1186/1471-2334-14-385. BMC Infect Dis. 2014. PMID: 25015848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

62 results

Results by year